发明名称 Systems and methods for treatment planning based on plaque progression and regression curves
摘要 Systems and methods are disclosed for evaluating a patient with vascular disease. One method includes receiving patient-specific data regarding a geometry of the patient's vasculature; creating an anatomic model representing at least a portion of a location of disease in the patient's vasculature based on the received patient-specific data; identifying one or more changes in geometry of the anatomic model based on a modeled progression or regression of disease at the location; calculating one or more values of a blood flow characteristic within the patient's vasculature using a computational model based on the identified one or more changes in geometry of the anatomic model; and generating an electronic graphical display of a relationship between the one or more values of the calculated blood flow characteristic and the identified one or more changes in geometry of the anatomic model.
申请公布号 US9239905(B1) 申请公布日期 2016.01.19
申请号 US201514621129 申请日期 2015.02.12
申请人 HeartFlow, Inc. 发明人 Sankaran Sethuraman;Taylor Charles A.;Choi Gilwoo;Schaap Michiel;Zarins Christopher K.;Grady Leo J.
分类号 G06F19/26;G06F19/00 主分类号 G06F19/26
代理机构 Bookoff McAndrews, PLLC 代理人 Bookoff McAndrews, PLLC
主权项 1. A computer-implemented method of evaluating a patient with vascular disease, the method comprising: receiving patient-specific data regarding a geometry of the patient's vasculature; determining a plaque remodeling characteristic characterizing a propensity of the disease in the patient's vasculature to progress or regress; determining, using the received patient-specific data and the determined plaque remodeling characteristic, a geometric model of a progression or regression of disease at a location in the patient's vasculature; calculating a value of a blood flow characteristic within the patient's vasculature using a blood flow model determined based on the received patient-specific data and the determined plaque remodeling characteristic; and generating a treatment recommendation or risk assessment based on the value of the blood flow characteristic calculated using the blood flow model based on the received patient-specific data and the determined plaque remodeling characteristic.
地址 Redwood City CA US